In this preventative therapy, the effects on tumor–endothelial cell interactions under ligand-dependent conditions, i.e., in efnb2lox/lox control animals with physiological endothelial Ephrin-B2 expression (Figure 1a) were investigated. This evidence concerns the gene EFNB2 and neoplasm.